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ABSTRACT 
Application of mixed solvency has been employed in the present research work to develop a liquisolid system (Powder formulation) of 
poorly water soluble drug, cefixime (as model drug). Material and Methods: For poorly water soluble drug cefixime, combination of 
solubilizers such as sodium acetate, sodium caprylate and propylene glycol as mixed solvent systems were used to decrease the overall 
concentration of solubilizers required to produce substantial increase in solubility and thereby resulting in enhanced drug loading capacity 
of cefixime. The procured sample of cefixime was characterized by melting point, IR, UV and DSC studies. Stability studies of liquisolid 
system of cefixime were performed for two months at room temperature, 30˚C and 40˚C. All the formulations were physically, chemically, 
and microbiologically stable. Conclusion: Mixed solvency concept has been successfully employed for enhancing the drug loading of poorly 
water soluble drug, cefixime. 
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1. INTRODUCTION 
The technique of “Liquisolid compact” is a type of 
powdered solution technology 1-5. It is a novel method to 
improve the in vivo solubility of poorly water soluble drugs. 
The basic concept here is to convert the liquid form of drug 
into free flowing readily compressible powder. Here the 
liquid drug, drug solution, suspension or emulsion is 
converted into free flowing powder by simply adsorbing it 
on an inert carrier with addition of various excipients such 
as binder and others required to prepare the tablet and 
then the mass is compressed to tablet.  
Components 6 
Drug: Drugs of all class of BCS system of classification 
Non-volatile solvent: It must be inert, hydrophilic, having 
low viscosity and high boiling point. Eg: Polyethylene 
Glycols (liquids), Propylene Glycol, Glycerol.  
Carrier: These are material with high porosity and a wide 
surface area which serves as a base to adsorb the liquid 
form of drug. Eg: MCC, Methyl Cellulose, Ethyl Cellulose, 
and Starch. 
Coating material: These are fine materials of size 
range10nm-450nm. These should be highly adsorptive to 
cover the carrier particle to make it look dry. Eg: Aerosil 
200, Silica, and Syloid. 
Disintegrants, Lubricants, Glidants 6 
 
Figure 1: Molecular level diagram 
There is an absolute necessity of solubility of an amount of 
drug desired as per the strength of dosage form to be 
present in the minimum amount of the solvent to be used 
as solution. For this purpose a suitable solvent or solvent 
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system is to be selected. The main objectives of the present 
work are to develop a suitable solvent system to enhance 
the drug loading capacity by enhancing the solubility of 
drug in nonvolatile solvent by using mixed solvency 
concept in liquisolid system, increase the flow property by 
reducing the required volume of nonvolatile solvent. 
As per the mixed solvency concept 7, each and every 
substance present in the universe has got solubilizing 
property and each substance is a solubilizer. Each and 
every weaker solvent (for a solute) can be made a strong 
solvent by proper selection of solubilizers. A concentrated 
aqueous solution containing various water soluble 
substances may act as good solvent for poorly water 
soluble drugs. By combining various excipients, additive 
and synergistic solvent actions are expected which has 
advantage of reducing the toxicities. For a desired 
solubility enhancement, a single solubilizer may prove 
toxic for human being but the combination of different 
excipients in safe smaller concentrations solves the 
problem of toxicity for same desired solubility of drug. The 
solubilities of a large number of poorly water soluble drugs 
have been enhanced by the mixed solvency concept.8-23 
Also, use of multiple solubilizers reduces the amount of 
individual solubilizers, rendering it towards their safe use. 
Moreover, it also emerges as a tool to increase the drug 
loading in the same solvent, earlier having less room for 
drug and skipping the use of alternate solvent which is 
more likely of organic nature. After the use of mixed 
solvency concept, the solvent emerges as mixed solvent 
system.  
 Cefixime 24, 25 is a broad-spectrum, 3rd-generation 
cephalosporin antibiotic which is derived semi-
synthetically from the marine fungus Cephalosporium 
acremonium with antibacterial activity. Cefixime inhibits 
the bacterial cell wall synthesis by disrupting 
peptidoglycan synthesis, resulting decrease in the cell wall 
stability and bacterial cell lysis.Cefixime is stable in the 
presence of a variety of beta-lactamases. Cefixime is more 
active against gram-negative bacteria and less active 
against gram-positive bacteria compared to second-
generation cephalosporin. 
 Application of the mixed solvency concept has been used 
to enhance the drug loading capacity in liquisolid system 
and to increase the flow property by reducing the required 
volume of nonvolatile solvent and enhance the solubility of 
drug in nonvolatile solvent. Cefixime was selected as model 
poorly water soluble drug for exploring the mixed solvency 
concept to enhance the solubility and hence to enhance the 
release rate of drug. 
2. MATERIALS AND METHODS 
2.1 Materials: Cefixime was obtained as a gift sample from 
Schon pharmaceutical limited, Indore. 
2.2 Preparation of calibration curve of cefixime in 
demineralized water:  
50 mg of pure drug was accurately weighed and 
transferred into a 500 ml volumetric   flask. It was 
dissolved with 300 ml of demineralized water and volume 
was made upto 500 ml with demineralized water to obtain 
stock solution of 100µg/ml. From the stock solution, 
appropriate dilutions were prepared in the range of 5-
25µg/ml. Absorbances of resulting solutions were noted at 
288 nm against demineralized water. The data were 
graphically represented in Figure 2.  
2.3 Determination of interference of excipients in the 
spectrophotometric estimation of cefixime: 
For determination of interference of additives in the 
spectrophotometric estimation of cefixime, the 
absorbances of the standard solutions of cefixime were 
determined in DM water alone and in the presence of fairly 
large concentrations of solubilizers. For this, 50 mg of drug 
was dissolved in 450ml of demineralized water in a 500 ml 
volumetric flask and shaken until a clear solution was 
formed and then the volume was made upto 500 ml with 
demineralized water to make stock solution of drug 
(100µg/ml). Then, 10 ml of the above solution was taken 
and diluted upto 50ml with demineralized water. This 
gives a solution of 20µg/ml. Likewise, excipient solution 
was prepared by dissolving 2000mg of each solubilizers in 
50ml distilled water and volume was made upto 100ml 
with demineralized water, to obtain 20,000µg/ml stock 
solution. From the above solution, 20ml of stock solution of 
drug (100µg/ml) and 10ml of stock solution of excipient 
(20,000 µg/ml) was taken and volume was made upto 
100ml with demineralized water. The absorbances were 
recorded against respective reagent blank at 288nm and 
results are shown below in table 2. A UV –visible recording 
spectrophotometer (shimadzu 1700) with 1 cm matched 
silica cells was employed for spectrophotometric 
determination.  
2.4 Drug excipient interaction studies:  
The compatibility of the drug with the excipient was 
assessed by drug-excipient interaction studies. The drug 
was mixed with excipient in 1:1 ratio in separate clear glass 
vials which were then properly sealed and kept 
undisturbed at different temperature conditions; at room 
temperature, and in refrigerator for a period of one month. 
After every week, vials were withdrawn and contents were 
observed for any change in their physical appearance.  
2.5 Solubility studies: 
In order to carry out the equilibrium solubility of cefixime 
in various blends , 4ml of each blend was taken in 10 ml 
vials and then excess amount of drug was added in each 
vials .Then vials were subjected to continuous shaking in 
water bath at room temperature in incubator shaker for 
24hours. All vials were containing suspension of drug. 
Then vials were kept undisturbed for 12 hours. After 
filtration through filter paper, the filtrates were suitably 
diluted with demineralized water and absorbances were 
measured at 288nm.Then, equilibrium solubility of drug in 
each blends were calculated by using calibration curve. 
Results are shown in table 3. 
2.6 Formulation development of Liquisolid system 
(Powder):  
Based on the solubility studies, liquisolid system were 
prepared using blend [25% Sodium Caprylate+12.5% 
Sodium Acetate] was taken (4 ml) and accurately weighed 
2000 mg drug was dissolved in it by mixing it in the 
cleaned and dried pestle mortar by trituration yielding a 
yellow colored clear solution. To the solution, gross 
amount of Starch 1500 (36,000 mg) and Tricalcium 
phosphate (28,000 mg) as carriers were added and allowed 
to adsorb the drug. The mixture was then triturated to 
allow and check the uniform mixing and adhesiveness of 
the powder and the remaining amount of carrier was again 
added to reduce the adhesiveness. 
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Table 1: Formula for liquisolid system of cefixime: 
Batch No. Carrier Drug added 
(mg) 
Amount of carrier 
used (mg) 
Volume of 
blend used (ml) 
Net weight 
(mg) 
LSC-01 Tricalcium phosphate 2000 28,000 4 31,500 
LSC-02 Starch 1500 2000 36,000 4 43,500 
 
2.7 Stability studies: Liquisolid systems of cefixime of two 
different formulations were kept at different storage 
conditions. Formulations were kept at room temperature, 
at 30°C and at 40°C. 
3. Evaluations of Liquisolid system:  
3.1Thin Layer Chromatography (TLC) analysis: TLC 
analysis was done to identify any drug-solubilizer 
interaction (table 4). Methanol was used as solvent for 
sample preparation for TLC of drug.  
3.2 Flow property 
Tapped density is considered as a basic parameter to judge 
the flow behavior and a tool to judge the compressibility of 
the powders. It determines the efficiency of compression 
and is responsible for affecting various parameters. 
The tapped density of the liquisolid system thus developed 
was calculated by Electro lab Tap density Tester by USP II 
method 
Weight of sample = 27.66 gm 
Initial Volume (V0) = 67mL 
Volume after 500 tapping (V1) = 62 ml 
 Volume after 750 tapping (V2) = 61ml 
Volume after 1250 tapping (V3) = 61 ml 
4.0 RESULTS AND DISCUSSION 
4.1 Preparation of calibration curve of cefixime in 
demineralized water:  
 
Figure 2: Calibration curve of cefixime in 
demineralized water 
4.3 Drug-solubilizers interference studies in the 
spectrophotometric estimation of cefixime: Observing 
the results of drug-solubilizers interference study, it was 
concluded that there was no interference in UV 
spectrophometric analysis of cefixime due to excipients.
 
Table 2: Drug-solubilizers interference studies in the spectrophotometric estimation of cefixime 
S.No. 
 
Cefixime and/or 
Excipient 
Drug concentration 
(µg/ml) 
Solubilizer concentration 
(µg/ml) 
Absorbance 
at 288nm 
Interference 
 
1 Cefixime 20 --- 0.737 --- 
2 Cefixime + sodium acetate 20 2000 0.734 NO 
3 Cefixime + sodium aprylate 20 2000 0.736 NO 
 
4.4 Drug solubilizers incompatibility studies: Observing 
the results of drug-solubilizers imcompatibility study it 
was concluded that there was no physical incompatibility 
between drug and selected formulation solubilizers. 
4.5 Formulation development: 
4.5.1 Solubility studies: Maximum increase in solubility 
of cefixime was observed in Blend F (25% S.C. + 12.5% 
S.A) so this blend was selected for preparing the 
formulation of liquisolid system of cefixime. 
 
Table 3: Solubility studies of cefixime in various aqueous solutions of solubilizers 
S.No. Blend Composition of blends Solubility  
(mg/ml) 
Solubility 
(%w/v) 
1 A 20% Sodium caprylate 320.25 7.15 
2 B 20% Sodium caprylate, 10% β Cyclodextrin 160.45 3.57 
3 C 15 %Sodium caprylate, 15 % Sodium acetate 250.56 4.46 
4 D 10% Sodium caprylate, 10% Sodium acetate 190.32 4.24 
5 E 1:1 PEG 400 & Propylene glycol, 15% Sodium caprylate 354.25 7.91 
6 F 25% Sodium caprylate, 12.5% Sodium acetate 476.67 10.64 
7 G 20% Sodium caprylate, 5% PVP K25 370 8.26 
8 H 10% Sodium acetate, 5% PVP K25 325 7.25 
y = 0.0392x 
R² = 0.9986 
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4.5.2 Stability studies: Stability studies of Liquisolid 
system of cefixime were performed for two months at 
room temperature, 30˚C and 40˚C and percent drug 
remaining for first formulation (Batch First) at room 
temperature was 97.07% and at 30˚C was 98.88% and at 
40˚C was 96.45%. Percent drug remaining for second 
formulation (Batch Second) at room temperature was 
97.89%, at 30˚C was 97.44% and at 40˚C was 96.32%. The 
results of stability studies of cefixime liquisolid system 
(powder) were reasonably good. 
4.6 Evaluations: 
4.6.1 TLC analysis: From TLC study, it is clear that there is 
no significant change in Rf value indicating that there were 
no interactions between drug and solubilizers.  
4.6.2 Densities: 
Tapped density (ρT) =0 .452gm/ml 
Bulk density (ρB) = 0.413 gm/ml 
Table 4: TLC analysis of pure cefixime and its 
formulations 
S. No. Solvent system Rf value 
1. Drug in methanol 0.45 
2. Drug in blend F 0.41 
 
5.  CONCLUSION 
Mixed solvency concept has been wisely used to develop a 
fast release formulation of poorly water soluble drug, 
cefixime by liquisolid technique using non-volatile solvent 
such as propylene glycol and various blend of solubilisers 
such as sodium caprylate and sodium acetate for enhancing 
the solubility of drug and thereby enhancing the drug 
loading of formulation. 
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